You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Glenmark Pharms Ltd Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS LTD, and what generic and branded alternatives to GLENMARK PHARMS LTD drugs are available?

GLENMARK PHARMS LTD has fifty-nine approved drugs.

There are seven tentative approvals on GLENMARK PHARMS LTD drugs.

Summary for Glenmark Pharms Ltd
US Patents:0

Drugs and US Patents for Glenmark Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd ATOMOXETINE HYDROCHLORIDE atomoxetine hydrochloride CAPSULE;ORAL 079019-005 May 30, 2017 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 204730-001 Mar 11, 2016 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 205566-001 Apr 7, 2017 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 203281-003 May 25, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.